Form 4: Outset Medical Director D. Keith Grossman Reports Acquisition of 8,983 Shares via RSU Grant

Outset Medical, Inc. Director D. Keith Grossman reported the acquisition of 8,983 shares of common stock on June 2, 2025, primarily through a Restricted Stock Unit grant, as disclosed in a recent SEC Form 4 filing.

Summary

• D. Keith Grossman, a Director at Outset Medical, Inc. (OM), reported changes in his beneficial ownership of the company's common stock via an SEC Form 4 filing.
• On June 2, 2025, Mr. Grossman acquired 8,983 shares of common stock at a price of $0.0, indicating a grant rather than a market purchase.
• These 8,983 shares are Restricted Stock Units (RSUs) that are scheduled to vest 100% upon the earlier of the one-year anniversary of the grant date or the date of the Issuer's next Annual Meeting of Stockholders.
• Following this transaction, Mr. Grossman directly owns 13,918 shares and indirectly owns 12,845 shares through the Grossman Fam Trust, resulting in a total beneficial ownership of 26,763 shares.
• All reported share numbers have been adjusted to reflect the 1-for-15 reverse stock split effected by Outset Medical on March 20, 2025.

Sentiment

Score: 6

Explanation: The acquisition of shares by a director through an RSU grant is generally a positive signal of alignment with shareholder interests. However, as a routine insider transaction report, it does not provide significant new operational or financial information to warrant a very high score.

Positives

• The grant of Restricted Stock Units to a director aligns their interests with long-term shareholder value creation, as the value of the grant is tied to the company's stock performance.
• A director acquiring shares, even through an RSU grant, can signal confidence in the company's future prospects and strategic direction.

Future Outlook

The document, an SEC Form 4, primarily reports an insider transaction and does not provide a general future outlook or financial guidance for the company, beyond the specific vesting schedule for the granted RSUs.

Industry Context

This Form 4 filing is a routine disclosure of an insider's change in beneficial ownership, which is a standard regulatory requirement for all publicly traded companies. It does not provide specific industry context or broader market trends.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests directly with the company's stock performance, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The 8,983 Restricted Stock Units granted to D. Keith Grossman are expected to vest 100% upon the earlier of the one-year anniversary of the grant date (June 2, 2026) or the date of Outset Medical's next Annual Meeting of Stockholders.

Key Dates

Keywords

Outset Medical, OM, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU Grant, Director Compensation, Reverse Stock Split